EVAS THERAPEUTICS LLC

Company Information
Address 613 HUNTLEY HEIGHTS DR
BALLWIN, MO, 63021-5876


Information

DUNS: 143727191

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Novel antithrombotic agents to prevent hemodialysis vascular access failure

    Amount: $1,365,616.00

    DESCRIPTION (provided by applicant): Currently, more than 60 % of end-stage renal diseases patients who require chronic hemodialysis are accessed through a native arteriovenous fistula (AVF) or synthe ...

    SBIRPhase II2012Department of Health and Human Services
  2. Pharmacologic treatment of thromboembolism

    Amount: $167,481.00

    DESCRIPTION (provided by applicant): Thromboembolic disorders are major causes of morbidity and mortality in the Western societies. Anticoagulants are pivotal agents in the prevention and treatment of ...

    SBIRPhase I2009Department of Health and Human Services
  3. Novel Recombinant Anticoagulant Proteins

    Amount: $152,652.00

    DESCRIPTION (provided by applicant): Phase I: Clot formation in the blood vessel (thrombosis) causes a broad range of serious clinical conditions, such as unstable angina, acute myocardial infarction, ...

    SBIRPhase I2005Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government